Thyrocare Technologies Q4 profit rises 22%; board declares ₹21 final dividend

Thyrocare Technologies posted a 22% year-on-year rise in Q4 net profit to ₹21.7 crore, driven by improved operational performance and a 70% jump in EBITDA.

Leave a Reply

Your email address will not be published. Required fields are marked *